A Study to Evaluate Molnupiravir Tablet Formulation Compared to the Molnupiravir Capsule Formulation in Healthy Adult Participants (MK-4482-011)
Clinical trial NCT06615869 · COMPLETED
Trial details
- NCT number
- NCT06615869
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-20
- Primary completion
- 2023-02-27
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.